Helius Medical Technologies (TSE:HSM) Stock Price Down 1.9%
Helius Medical Technologies Inc (TSE:HSM)’s stock price dropped 1.9% during mid-day trading on Thursday . The company traded as low as C$2.52 and last traded at C$2.55, approximately 1,100 shares changed hands during mid-day trading. A decline of 95% from the average daily volume of 22,855 shares. The stock had previously closed at C$2.60.
The company has a market capitalization of $69.32 million and a price-to-earnings ratio of -7.45. The company has a debt-to-equity ratio of 5.56, a quick ratio of 3.15 and a current ratio of 3.40. The business has a 50 day moving average price of C$2.83 and a 200-day moving average price of C$5.19.
Helius Medical Technologies (TSE:HSM) last announced its quarterly earnings data on Thursday, August 8th. The company reported C($0.29) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C($0.34) by C$0.05. The business had revenue of C$0.69 million during the quarter, compared to analyst estimates of C$0.54 million. As a group, equities analysts predict that Helius Medical Technologies Inc will post 0.12 EPS for the current fiscal year.
Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury.
Recommended Story: Do equity income investments outperform growth and income investments?
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.